Wendy Sanchez Quiroa
Psychiatric/Mental Health · Orlando, FLNPI 1982291100
Payments from drug & device makers
Across 182 payments — averaging $25.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$571
- Axsome Therapeutics, Inc.$459
- Neurocrine Biosciences, Inc.$405
- Alkermes, Inc.$303
- Otsuka America Pharmaceutical, Inc.$270
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,53599%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,321 |
| Johnson & Johnson(2 entities) | 18 | $571 |
| Axsome Therapeutics, Inc. | 11 | $459 |
| Neurocrine Biosciences, Inc. | 8 | $405 |
| Alkermes, Inc. | 20 | $303 |
| Otsuka America Pharmaceutical, Inc. | 14 | $270 |
| Teva Pharmaceuticals USA, Inc. | 9 | $175 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $145 |
| E.r. Squibb & Sons, L.L.C. | 6 | $132 |
| Supernus Pharmaceuticals, Inc. | 1 | $126 |
| Idorsia Pharmaceuticals US Inc | 7 | $120 |
| Pfizer | 5 | $103 |
| Novo Nordisk | 4 | $78 |
| GSK | 2 | $63 |
| Lundbeck LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Novartis | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Eisai Inc. | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $14 |
| Seagen Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,562 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 140 | $225,056 |
| VraylarCariprazine Hcl | 124 | $166,580 |
| Abilify MaintenaAripiprazole | 26 | $66,633 |
| CaplytaLumateperone Tosylate | 34 | $54,358 |
| LybalviOlanzapine/Samidorphan Malate | 33 | $50,094 |
| AtivanLorazepam | 12 | $48,072 |
| TrintellixVortioxetine Hydrobromide | 51 | $25,999 |
| Aripiprazole | 187 | $25,140 |
| BelsomraSuvorexant | 58 | $24,977 |
| QuviviqDaridorexant Hcl | 40 | $19,152 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $12,803 |
| Duloxetine Hcl | 250 | $8,303 |
| Quetiapine Fumarate | 532 | $5,080 |
| Lurasidone Hcl | 25 | $4,155 |
| Paliperidone ErPaliperidone | 14 | $3,532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $270 | $291,689166 claims |
| AbbVieVraylar | $1,321 | $166,580124 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $145 | $54,35834 claims |
| Alkermes, Inc.Lybalvi | $303 | $50,09433 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $58 | $25,99951 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $120 | $19,15240 claims |
| Axsome Therapeutics, Inc.Auvelity | $459 | $12,80312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.